Gastrointestinal effects Nausea, the most common side effect, tends to reappear during dose escalation periods
It affects a significant majority of people starting GLP-1 treatment, with studies showing that 40 to 50 percent of patients experience nausea, particularly during dose escalation
Worsened gastrointestinal side effects Like other GLP-1 medications , semaglutide slows gastric emptying (i.e
Most patients report meaningful appetite suppression within the first two weeks, though the exact timing varies based on individual metabolism, starting dose, and genetic factors affecting GLP-1 receptor sensitivity
Patients find peace of mind by selecting our multi-box bundles (up to 5 Boxes), ensuring uninterrupted therapeutic coverage while benefiting from streamlined, secure global cold-chain delivery right to their door